These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18026137)

  • 41. Nano-encapsulated tryptanthrin derivative for combined anticancer therapy via inhibiting indoleamine 2,3-dioxygenase and inducing immunogenic cell death.
    Yang C; He B; Zheng Q; Wang D; Qin M; Zhang H; Dai W; Zhang Q; Meng X; Wang X
    Nanomedicine (Lond); 2019 Sep; 14(18):2423-2440. PubMed ID: 31549585
    [No Abstract]   [Full Text] [Related]  

  • 42. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
    Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
    J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase].
    Beutelspacher SC; Serbecic N
    Klin Monbl Augenheilkd; 2008 Aug; 225(8):703-7. PubMed ID: 18712654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage.
    Mehta RG; Liu J; Constantinou A; Thomas CF; Hawthorne M; You M; Gerhüser C; Pezzuto JM; Moon RC; Moriarty RM
    Carcinogenesis; 1995 Feb; 16(2):399-404. PubMed ID: 7859373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
    Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR
    Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomimetic synthesis of the IDO inhibitors exiguamine A and B.
    Volgraf M; Lumb JP; Brastianos HC; Carr G; Chung MK; Münzel M; Mauk AG; Andersen RJ; Trauner D
    Nat Chem Biol; 2008 Sep; 4(9):535-7. PubMed ID: 18677305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha-galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells.
    Fallarini S; Paoletti T; Panza L; Lombardi G
    Biochem Pharmacol; 2008 Sep; 76(6):738-50. PubMed ID: 18671950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma.
    Jia H; Ren W; Feng Y; Wei T; Guo M; Guo J; Zhao J; Song X; Wang M; Zhao T; Wang H; Feng Z; Tian Z
    Int J Oncol; 2018 Sep; 53(3):949-960. PubMed ID: 30015838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of indoleamine 2,3-dioxygenase on transplantation immunity].
    Duan X; Cui P; Jiang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb; 22(2):230-3. PubMed ID: 18365624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor models.
    Tejeda M; Gaál D; Hullán L; Schwab R; Szokoloczi O; Kéri G
    Anticancer Res; 2007; 27(6B):4015-9. PubMed ID: 18225564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
    Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
    Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brassinin oxidase mediated transformation of the phytoalexin brassinin: structure of the elusive co-product, deuterium isotope effect and stereoselectivity.
    Pedras MS; Minic Z; Sarma-Mamillapalle VK
    Bioorg Med Chem; 2011 Feb; 19(4):1390-9. PubMed ID: 21292494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mouse model for allogeneic immune reaction against fetus recapitulates human pre-eclampsia.
    Nishizawa H; Hasegawa K; Suzuki M; Achiwa Y; Kato T; Saito K; Kurahashi H; Udagawa Y
    J Obstet Gynaecol Res; 2008 Feb; 34(1):1-6. PubMed ID: 18226121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy.
    Lin SY; Yeh TK; Song JS; Hung MS; Cheng MF; Liao FY; Li AS; Cheng SY; Lin LM; Chiu CH; Wu MH; Lin YJ; Hsiao W; Sun M; Wang YH; Huang CH; Tang YC; Chang HH; Huang ZT; Chao YS; Shih C; Pan SL; Wu SY; Kuo CC; Ueng SH
    Bioorg Chem; 2018 Apr; 77():600-607. PubMed ID: 29494816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brassinin Inhibits Proliferation in Human Liver Cancer Cells via Mitochondrial Dysfunction.
    Hong T; Ham J; Song J; Song G; Lim W
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IDO is a nodal pathogenic driver of lung cancer and metastasis development.
    Smith C; Chang MY; Parker KH; Beury DW; DuHadaway JB; Flick HE; Boulden J; Sutanto-Ward E; Soler AP; Laury-Kleintop LD; Mandik-Nayak L; Metz R; Ostrand-Rosenberg S; Prendergast GC; Muller AJ
    Cancer Discov; 2012 Aug; 2(8):722-35. PubMed ID: 22822050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.